Controversies in the Cellular Pharmacology of Oligodeoxynucleotides
- 1 June 1997
- journal article
- review article
- Published by Mary Ann Liebert Inc in Antisense and Nucleic Acid Drug Development
- Vol. 7 (3) , 207-209
- https://doi.org/10.1089/oli.1.1997.7.207
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Protein kinase C and its substratesMolecular and Cellular Endocrinology, 1996
- Interaction of Oligodeoxynucleotides with Mammalian CellsAntisense and Nucleic Acid Drug Development, 1996
- Transport of phosphorothioate oligonucleotides in kidney: Implications for molecular therapyKidney International, 1995
- Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides.Journal of Clinical Investigation, 1995
- Inhibition of Human Immunodeficiency Virus Type-1 env Expression by C-5 Propyne Oligonucleotides Specific for Rev-Response Element Stem-Loop VBiochemistry, 1994
- Transport of oligonucleotides across natural and model membranesBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1994
- Dynamics of the internalization of phosphodiester oligodeoxynucleotides in HL60 cellsBiochemistry, 1993
- Inhibitors of protein kinase C. 3. Potent and highly selective bisindolylmaleimides by conformational restrictionJournal of Medicinal Chemistry, 1993
- Binding of oligonucleotides to cell membranes at acidic pHBiochemical and Biophysical Research Communications, 1991
- CELL MEMBRANE DNA: A NEW TARGET FOR PSORALEN PHOTOADDUCT FORMATIONPhotochemistry and Photobiology, 1990